后COVID-19疫苗接种中等血管血管炎:病例报告的系统审查
Vivek Sanker1, Maneeth Mylavarapu2, Prakash Gupta3
1Department of Neurosurgery, Trivandrum Medical College, Thiruvananthapuram, India.
Infection
|March 14, 2024
概括
接种COVID-19疫苗可能很少导致中等血管血管炎,通常发生在接种疫苗后16.2天. 这种罕见的并发症在第二剂疫苗接种后主要在男性中观察到,需要进一步调查以明确治疗方案.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 类风湿病学 类风湿病学
背景情况:
- 接种疫苗对于应对COVID-19流行病等全球卫生危机至关重要.
- 了解免疫接种后的潜在不良事件对于公共卫生至关重要.
研究的目的:
- 调查COVID-19疫苗接种和中等血管血管炎的发展之间的潜在关联.
- 分析COVID-19疫苗接种后血管炎病例的特征和时间.
主要方法:
- 使用多个数据库进行了全面的文献审查.
- 病例报告的质量和潜在偏见得到了严格的评估.
- 在审查了935个搜索结果后,选择了10个相关的案例报告.
主要成果:
- 中等血管血管炎可以在COVID-19疫苗接种后表现出来.
- 血管炎的发作发生在接种疫苗后大约16.2天.
- 病例主要观察到男性 (80%),平均年龄为43.5岁,50%发生在第二剂疫苗接种后.
结论:
- 疫苗接种相关的血管炎是COVID-19疫苗的罕见但潜在的并发症.
- 目前还没有确定的治疗方案来治疗这种疾病.
- 需要进一步的研究来理解和管理这种罕见的不良事件.
相关概念视频
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...


